Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities... Show more
CME Group Inc. (CME) shares ended the most recent session at $264.48, down 1.65% on the day, with after-hours trading near $264.50. Over the past 30 days, the stock has declined approximately 7.5% from $285.80, a move that stands in contrast to the broader recovery the equity staged during the summer months. The shares remain comfortably above their June 29 52-week low of $218.31 but well below their March 2026 52-week high of $329.16.
The recent decline has occurred despite resilient underlying business metrics, suggesting the move reflects a moderation in momentum and valuation-driven consolidation following a rapid run-up rather than a deterioration in fundamentals. CME's low beta of roughly 0.27 underscores its defensive, low-correlation profile relative to the broader equity market.
CME Group is the world's leading derivatives marketplace, operating exchanges that include CME, CBOT, NYMEX, and COMEX. The company provides futures and options trading and clearing across interest rates, equity indexes, foreign exchange, energy, agriculture, and metals, alongside a fast-growing market data and information services segment.
Its competitive advantages stem from deep liquidity pools and network effects, regulated central clearing infrastructure, and an asset-light electronic trading model that supports high margins and strong free cash flow. These qualities have historically translated into a low-beta, capital-return-oriented profile. CME competes with other exchange and market-infrastructure operators, including Intercontinental Exchange, Nasdaq, and S&P Global, while maintaining a leadership position in the global futures and options market.
CME reported second-quarter 2026 results on July 22, with adjusted diluted EPS of $2.99 surpassing the consensus estimate of $2.91 and revenue of $1.71 billion edging past the $1.68 billion forecast. The quarter was highlighted by record market data revenue, which rose 20% year over year, and average daily volume of 29.8 million contracts, the third-highest quarterly level in company history. For the first half of 2026, the company posted record revenue, adjusted operating income, and adjusted EPS.
Through September, volume trends remained robust. CME reported August ADV of 29.7 million contracts, its second-highest on record, and set a new open interest record in its foreign exchange complex. The company also continued to broaden its product suite, announcing plans to launch Bitcoin Cash and Uniswap futures, entering the European dairy market through a transition of EEX dairy products, launching Liquid Leveraged Loan Index futures, and outlining a new SEC-registered Treasury clearing house scheduled for December. Management also announced several senior leadership appointments, including a new chief financial officer.
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots from a platform that offers hundreds of bots trading thousands of tickers. Only the top-performing and most relevant bots appear in this section, which is continually refreshed to reflect evolving market conditions. The bots vary widely in strategy, timeframe, and performance metrics, enabling traders to compare approaches ranging from short-term momentum to longer-horizon trend following. For investors monitoring names like CME Group as part of a broader portfolio, these tools offer an additional data-driven perspective on market behavior. Explore the Trending AI Robots page to review the current selections and their performance.
Looking ahead, investors will focus on CME's third-quarter earnings report, scheduled for October 21, 2026, where management's commentary on trading volumes, average rate per contract, and expense guidance will be central. Consensus estimates call for full-year 2026 revenue of roughly $7.03 billion, implying about 7.8% year-over-year growth, with further expansion expected in 2027.
Key drivers to monitor include interest-rate futures activity as monetary policy expectations evolve, continued growth in the market data segment, and the contribution of newer initiatives such as Treasury Link, Compute futures, and expanded cryptocurrency and 24/7 metals trading. Risks include a sustained decline in market volatility, competitive pressure in derivatives and market data, and regulatory or tax policy changes affecting futures and options markets.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CME may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 22 of 35 cases where CME's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 63%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where CME advanced for three days, in 178 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.
The 10-day RSI Indicator for CME moved out of overbought territory on September 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 20 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.
The Momentum Indicator moved below the 0 level on September 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CME as a result. In 46 of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.
The Moving Average Convergence Divergence Histogram (MACD) for CME turned negative on September 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 25 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.
CME moved below its 50-day moving average on September 25, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CME crossed bearishly below the 50-day moving average on September 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 38%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.
The Aroon Indicator for CME entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 48 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. CME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.569) is normal, around the industry mean (-5.093). P/E Ratio (22.327) is within average values for comparable stocks, (25.252). CME's Projected Growth (PEG Ratio) (4.578) is very high in comparison to the industry average of (1.780). CME has a moderately high Dividend Yield (0.043) as compared to the industry average of (0.018). CME's P/S Ratio (14.535) is slightly higher than the industry average of (7.166).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of securities and commodity exchanges
Industry FinancialPublishingServices